Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Crescent Biopharma (CBIO) Times Interest Earned (2025)

Crescent Biopharma has reported Times Interest Earned over the past 1 years, most recently at -$19.6 for Q2 2025.

  • Quarterly Times Interest Earned changed N/A to -$19.6 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$152.04 through Mar 2026, down 341.1% year-over-year, with the annual reading at -$69.85 for FY2025, 246.2% down from the prior year.
  • Times Interest Earned was -$19.6 for Q2 2025 at Crescent Biopharma, down from -$12.79 in the prior quarter.
  • Over five years, Times Interest Earned peaked at -$12.79 in Q1 2025 and troughed at -$19.6 in Q2 2025.